Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
T-3011 by Immvira for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
T-3011 is under clinical development by Immvira and currently in Phase II for Recurrent Head And Neck Squamous Cell Carcinoma....
T-3011 by Immvira for Malignant Ascites: Likelihood of Approval
T-3011 is under clinical development by Immvira and currently in Phase I for Malignant Ascites. According to GlobalData, Phase I...
T-3011 by Immvira for Metastatic Colorectal Cancer: Likelihood of Approval
T-3011 is under clinical development by Immvira and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...
T-3011 by Immvira for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
T-3011 is under clinical development by Immvira and currently in Phase I for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial...